Form 4 for GRCE Grace Therapeutics, Inc.
Accepted 2026-09-10 07:30:38 ET · period of report 2026-09-09 · accession 0001140361-26-036125 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 07:30 | 2026-09-09 | GRCE | Kohli Prashant | CEO, Dir | P - Purchase | $2.14 | +100.0K | 121.4K | +468% | +$214.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-09 | P | A | 100,000 | $2.14 | 121,357 | D | — | — |